2025

• 05
  • AITRICS-VC (VitalCare) received medical device approval in Hong Kong
• 03
  • Established the Japan office of AITRICS
• 01
  • Recognized as one of the Top 100 Emerging AI+X of 2024

2024

• 12
  • AITRICS has obtained New Excellent Technology(NET) designated by the Ministry of Health and Welfare
• 11
  • AITRICS has signed an MOU with Dong-A ST
• 10
  • AITRICS-VC (VitalCare) received medical device approval in Vietnam
• 08
  • AITRICS has received FDA 510(k) Clearance
• 07
  • AITRICS has signed an MOU with ezCaretech
  • AITRICS has signed an MOU with EWHA WOMANS UNIVERSITY College of Medicine
• 06
  • AITRICS has signed an MOU with MEZOO
• 04
  • AITRICS has signed an MOU with Korea University Anam Hospital
• 03
  • AITRICS raises ₩27.1 billion in Series B funding
• 01
  • AITRICS has signed an MOU with Chung-Ang University Hospital
  • Recognized as one of the Top 100 Emerging AI+X of 2024
  • Certified as the No. 6 innovative medical device software manufacturer by the Ministry of Food and Drug Safety for AITRICS-VC(VitalCare)

2023

• 12
  • Established the U.S. office of AITRICS
• 11
  • Won the Minister’s Award at the AI Reliability and Quality Awards
• 08
  • AITRICS has signed an MOU with Eunsung Medical Foundation
• 07
  • AITRICS has signed an MOU with Philips Korea
• 03
  • Entered the non-benefit medical service market with AITRICS-VC(VitalCare)
• 02
  • Issued a notice of conditional nHTA (new Health Technology Assessment) approval by the Ministry of Health and Welfare for AITRICS-VC(VitalCare)
• 01
  • Selected AITRICS-VC(VitalCare) for eligibility in the conditional nHTA (new Health Technology Assessment) approval program

2022

• 12
  • Designated AITRICS-VC (Vital Care) as the No. 27 innovative medical device by the Ministry of Food and Drug Safety
• 11
  • Recognized as one of the Top 12 winners of the 11th Medical Startup Competition, the only one of its kind in South Korea
• 10
  • Approved by MFDS for AITRICS-VC(VitalCare)
• 04
  • ISO13485 and ENIS013485 certified
  • Obtained final approval from the Ministry of Food and Drug Safety for a clinical trial of AITRICS-VC(VitalCare)

2021

• 10
  • Published retrospective clinical results for predicting major adverse events in ICUs in JMIR Medical Informatics 2021
• 03
  • Formed a collaborative research agreement with Asan Medical Center

2020

• 09
  • Selected as a participant of the "Data-Labeling for AI Learning Project" led by the Ministry of Science and ICT
• 03
  • Selected for the Global ICT Future Unicorn Incubation Company (ICT growth) by the Ministry of Science and ICT
  • Obtained the Medical Device Quality Management System Certification from the Ministry of Food and Drug Safety for AITRICS-VC(VitalCare)

2019

• 05
  • Formed an MOU with Cleveland Clinic
• 03
  • Formed a collaborative research agreement with Yonsei University Health System

2018

• 11
  • Published the highest number of individual papers in NeurIPS for a domestic company, totaling seven.
• 02
  • Selected for the Tech Incubator Program for Startups (TIPS)

2017

• 10
  • Selected for the Future Technology Support Project by Samsung Electronics
• 07
  • Participated in the Explainable AI (XAI) National Assignment

2016

• 11
  • Established AITRICS